![Gavin Xia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gavin Xia
Nessuna posizione attualmente
Patrimonio netto: 179 M $ in data 31/07/2026
Profilo
Dr. Gavin Xia is a Chief Executive Officer at Alebund Pharmaceuticals (Jiangsu) Ltd., a Chief Executive Officer at Shanghai Alebund Pharmaceutical Technology Co., Ltd. and a Venture Partner at LAV Management Co., Ltd. Dr. Xia was previously employed as a Non-Executive Director by Abbisko Cayman Ltd. and a Non-Executive Director by Abbisko Therapeutics Co., Ltd. He also served on the board at Shanghai Kun Yuan Biotechnology Co. Ltd. and Beijing Jiakesi New Drug Development Co. Ltd. He received his undergraduate degree from Peking University and a doctorate degree from The University of Chicago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
11,33% | 29/06/2026 | 32.069.014 ( 11,33% ) | 111 M $ | 31/07/2026 |
8,54% | 29/07/2026 | 19.401.461 ( 8,54% ) | 67 M $ | 31/07/2026 |
Posizioni attive di Gavin Xia
| Società | Posizione | Inizio |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Investitore di Private Equity | - |
Shanghai Alebund Pharmaceutical Technology Co., Ltd.
 Shanghai Alebund Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company, focuses on novel therapies discovery and development for kidney diseases | Amministratore Delegato | - |
Precedenti posizioni note di Gavin Xia
| Società | Posizione | Fine |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Direttore/Membro del Consiglio | 19/06/2023 |
Shanghai Kun Yuan Biotechnology Co. Ltd. | Direttore/Membro del Consiglio | 01/02/2021 |
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells drugs | Direttore/Membro del Consiglio | - |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Direttore/Membro del Consiglio | - |
Formazione di Gavin Xia
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
98
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Finance |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells drugs | Health Technology |
Shanghai Alebund Pharmaceutical Technology Co., Ltd.
Shanghai Alebund Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company, focuses on novel therapies discovery and development for kidney diseases | Health Technology |
Abbisko Cayman Ltd.
 Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Shanghai Kun Yuan Biotechnology Co. Ltd. |
